Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/170
A mathematical model for the spatiotemporal epidemic spreading of COVID19
Wesley Cota
Jesus Gomez-Gardenes
Benjamin Steinegger
David Soriano-Panos
Joan T. Matamalas
Alex Arenas
Sergio Gómez
Clara Granell
Novel Coronavirus
Acceso Abierto
Atribución-NoComercial-SinDerivadas
10.1101/2020.03.21.20040022
An outbreak of a novel coronavirus, named SARS-CoV-2, that provokes the COVID-19 disease, was first reported in Hubei, mainland China on 31 December 2019. As of 20 March 2020, cases have been reported in 166 countries/regions, including cases of human-to-human transmission around the world. The proportions of this epidemics is probably one of the largest challenges faced by our interconnected modern societies. According to the current epidemiological reports, the large basic reproduction number, R_0 ~ 2.3, number of secondary cases produced by an infected individual in a population of susceptible individuals, as well as an asymptomatic period (up to 14 days) in which infectious individuals are undetectable without further analysis, pave the way for a major crisis of the national health capacity systems. Recent scientific reports have pointed out that the detected cases of COVID19 at young ages is strikingly short and that lethality is concentrated at large ages. Here we adapt a Microscopic Markov Chain Approach (MMCA) metapopulation mobility model to capture the spread of COVID-19. We propose a model that stratifies the population by ages, and account for the different incidences of the disease at each strata. The model is used to predict the incidence of the epidemics in a spatial population through time, permitting investigation of control measures. The model is applied to the current epidemic in Spain, using the estimates of the epidemiological parameters and the mobility and demographic census data of the national institute of statistics (INE). The results indicate that the peak of incidence will happen in the first half of April 2020 in absence of mobility restrictions. These results can be refined with improved estimates of epidemiological parameters, and can be adapted to precise mobility restrictions at the level of municipalities. The current estimates largely compromises the Spanish health capacity system, in particular that for intensive care units, from the end of March. However, the model allows for the scrutiny of containment measures that can be used for health authorities to forecast with accuracy their impact in prevalence of COVID--19. Here we show by testing different epidemic containment scenarios that we urge to enforce total lockdown to avoid a massive collapse of the Spanish national health system. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement A.A., B.S. and S.G. acknowledge financial support from Spanish MINECO (grant PGC2018-094754-B-C21), , Generalitat de Catalunya (grant No. 2017SGR-896), and Universitat Rovira i Virgili (grant No. 2018PFR-URV-B2-41). A.A. also acknowledge support from Generalitat de Catalunya ICREA Academia, and the James S. McDonnell Foundation grant #220020325. J.G.G. and D.S.P. acknowledges financial support from MINECO (projects FIS2015-71582-C2 and FIS2017-87519-P) and from the Departamento de Industria e Innovación del Gobierno de Aragón y Fondo Social Europeo (FENOL group E-19). C.G. acknowledges financial support from Juan de la Cierva-Formación (Ministerio de Ciencia, Innovación y Universidades). B.S. acknowledges financial support from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 713679 and from the Universitat Rovira i Virgili (URV). W.C. acknowledges financial support from the Coordenacão de Aperfeiçoamento de Pessoal de Nível Superior, Brasil (CAPES), Finance Code 001. ### Author Declarations All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript. Yes All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes All data will be available upon request.
Cold Spring Harbor Laboratory Press
2020
Preimpreso
https://www.medrxiv.org/content/10.1101/2020.03.21.20040022v1
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives